These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 18160532

  • 1. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.
    Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):663-7. PubMed ID: 18160532
    [Abstract] [Full Text] [Related]

  • 2. Lipid lowering with thyroid hormone and thyromimetics.
    Angelin B, Rudling M.
    Curr Opin Lipidol; 2010 Dec 15; 21(6):499-506. PubMed ID: 20935564
    [Abstract] [Full Text] [Related]

  • 3. The resurgence of thyromimetics as lipid-modifying agents.
    Tancevski I, Eller P, Patsch JR, Ritsch A.
    Curr Opin Investig Drugs; 2009 Sep 15; 10(9):912-8. PubMed ID: 19705333
    [Abstract] [Full Text] [Related]

  • 4. Thyromimetics: a journey from bench to bed-side.
    Tancevski I, Rudling M, Eller P.
    Pharmacol Ther; 2011 Jul 15; 131(1):33-9. PubMed ID: 21504761
    [Abstract] [Full Text] [Related]

  • 5. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L, Li YL, Mellström K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B, Persson K, Ljunggren J, Grover G, Sleph PG, George R, Malm J.
    J Med Chem; 2003 Apr 24; 46(9):1580-8. PubMed ID: 12699376
    [Abstract] [Full Text] [Related]

  • 6. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH, Brenta G.
    Med Clin North Am; 2012 Mar 24; 96(2):269-81. PubMed ID: 22443975
    [Abstract] [Full Text] [Related]

  • 7. Thyroid mimetic as an option for lowering low-density lipoprotein.
    Grundy SM.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):409-10. PubMed ID: 18187579
    [No Abstract] [Full Text] [Related]

  • 8. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future.
    Delitala AP, Delitala G, Sioni P, Fanciulli G.
    Curr Med Res Opin; 2017 Nov 15; 33(11):1985-1993. PubMed ID: 28498022
    [Abstract] [Full Text] [Related]

  • 9. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 15; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 10. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H, Miettinen TA.
    Nutr Metab Cardiovasc Dis; 2002 Feb 15; 12(1):19-23. PubMed ID: 12125225
    [Abstract] [Full Text] [Related]

  • 11. Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.
    Pedrelli M, Pramfalk C, Parini P.
    World J Gastroenterol; 2010 Dec 21; 16(47):5958-64. PubMed ID: 21157972
    [Abstract] [Full Text] [Related]

  • 12. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
    Tancevski I, Demetz E, Eller P.
    Recent Pat Cardiovasc Drug Discov; 2011 Jan 21; 6(1):16-9. PubMed ID: 21208155
    [Abstract] [Full Text] [Related]

  • 13. The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation.
    Szydlowska M, Pibiri M, Perra A, Puliga E, Mattu S, Ledda-Columbano GM, Columbano A, Leoni VP.
    Gene Expr; 2017 Jul 07; 17(3):207-218. PubMed ID: 28409553
    [Abstract] [Full Text] [Related]

  • 14. The effect of taurine on cholesterol metabolism.
    Chen W, Guo JX, Chang P.
    Mol Nutr Food Res; 2012 May 07; 56(5):681-90. PubMed ID: 22648615
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.
    Lind S, Rudling M, Ericsson S, Olivecrona H, Eriksson M, Borgström B, Eggertsen G, Berglund L, Angelin B.
    Arterioscler Thromb Vasc Biol; 2004 Feb 07; 24(2):349-56. PubMed ID: 14656733
    [Abstract] [Full Text] [Related]

  • 16. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 07; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 17. Note on the effects of thyroidectomy and thyroid hormone administration on the concentration of bile cholesterol and cholic acid.
    VAN ZYL A.
    J Endocrinol; 1957 Dec 07; 16(2):213-6. PubMed ID: 13491751
    [No Abstract] [Full Text] [Related]

  • 18. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
    Goldman S, McCarren M, Morkin E, Ladenson PW, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O'Brien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, Shih MC, Lavori P.
    Circulation; 2009 Jun 23; 119(24):3093-100. PubMed ID: 19506112
    [Abstract] [Full Text] [Related]

  • 19. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.
    Lin JZ, Martagón AJ, Hsueh WA, Baxter JD, Gustafsson JÅ, Webb P, Phillips KJ.
    Endocrinology; 2012 Dec 23; 153(12):6136-44. PubMed ID: 23087171
    [Abstract] [Full Text] [Related]

  • 20. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
    Sukonthasarn A, Homsanit M, Prommete B, Chotinaiwattarakul C, Piamsomboon C, Likittanasombat K.
    J Med Assoc Thai; 2011 Dec 23; 94(12):1424-34. PubMed ID: 22295727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.